Vortioxetine
Multimodal antidepressant • Brands: Trintellix
Last reviewed: 2025-09-26
General information
Indicated for: Major depressive disorder.
Dosing & forms
- Forms/strengths: —
- Frequency: —
- Food: —
- Typical range: 10–20 mg once daily
Mechanism (brief)
Serotonin transporter inhibition plus 5-HT receptor modulation (5-HT1A agonist, 5-HT1B partial agonist, 5-HT3/5-HT7 antagonist).
Metabolism & Half‑life
- Metabolism: CYP2D6 primary, CYP3A4 and CYP2C19 contribute.
- Half‑life: ~66 h.
Therapeutic Drug Monitoring (TDM)
Recommended: No
View labelExact
Monitoring highlights
- Monitor for nausea and GI intolerance — During initiation
- Assess for hyponatremia in older adults — Baseline and if symptomatic
Sources
- Vortioxetine label — DailyMed (2025)